Daily Archives: September 8, 2021

Clarity Pharmaceuticals lists on the ASX

Sydney, Australia 25 August 2021 Clarity Pharmaceuticals lists on the ASX today under code CU6 after raising $92.0 million at $1.40 per share, equating to an indicative market capitalisation of approximately $358.6million (on an undiluted basis) at the Offer price. Clarity is an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing…

First patient treated in Clarity’s Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial

Sydney, Australia 25 August 2021 – Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or the “Company”), an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, is pleased to announce that the first US patient has been dosed with 64Cu SAR-bisPSMA in the dosimetry phase of the SECuRE clinical trial (NCT04868604)1…